Clinical Trials |
| Jun 2018 | Medical device clinical trials in Australia – current challenges and a call-to-action |
| May 2018 | Response to ANZ CTR Discussion Paper |
| Apr 2018 | MTAA Position Statement and Response to RDTF Discussion Paper: Proposed model for an Australian Coordinating Body for Clinical Trials April 2018 |
| | |
COVID-19 |
| Mar 2020 | Joint position statement from MTAA, MA and AusBiotech on Clinical Trials |
| | |
GS1 Recallnet/RecallHealth |
| May 2016 | MTAA Updated Position Paper on GS1 Recallnet |
| Nov 2015 | MTAA Position Paper on GS1 Recallnet |
| | |
Medical Company Representatives |
| Mar 2019 | Joint AOA and MTAA position statement on orthopaedic MedTech company representatives (OMCRs) in operating rooms |
| | |
Senate Inquiry |
| Jun 2018 | MTAA Position Paper to the Senate Report: Number of women in Australia who have had transvaginal mesh implants and related matters |
| Jan 2018 | The effect of red tape on health services |
| Feb 2017 | Senate Inquiry into the Prostheses List Framework |
| | |
Standards |
| July 2019 | In-house service and refurbishment of medical equipment - understanding regulatory risk |
| Dec 2018 | Revision of AS/NZS 3551:2012 Management programs for medical equipment |
| | |
NZ Therapeutic Products |
| Apr 2019 | NZ Therapeutic Products Regulatory Scheme |
| | |
UDI |
| May 2018 | Joint MTAA, IVD Australia, ADIA and AusBiotech Policy Paper: UDI Implementation in Australia |
